Denemek ALTIN - Özgür

The Volkswagen robotaxi that wants to rival Waymo and Tesla

Mint Hyderabad

|

July 07, 2025

Self-driving VW minivans, now in Germany, coming to U.S. next year via Uber deal

- Stephen Wilmot

The self-driving taxi carefully steered around the delivery vehicle that blocked its path—and straight into oncoming traffic.

"Not the best driving decision," sighed Christian Senger, head of autonomous vehicles at Volkswagen, which built the robotaxi.

The incident, during an otherwise smooth test drive last month, underlines how Europe—once the world leader in automotive engineering—is playing catch-up with the U.S. and China.

Alphabet's Waymo has run fully driverless taxis in the U.S. for almost five years without serious mishap and now operates more than 250,000 rides a week. Similar services are available in cities across China, run by local tech companies such as Baidu.

With no homegrown tech giants and more onerous regulations, Europe has largely stayed out of the autonomous-driving race. Now, it's hitting the gas, eager to hedge its bets on the future of the auto industry and foster innovation after years of sluggish growth.

Hamburg is the emerging epicenter of the region's robotaxi push. About 30 specially adapted versions of the Volkswagen ID.Buzz electric minivan drive themselves around the city's crowded streets, bearing the black-and-bronze livery of the company's ride-pooling service, Moia.

With the technology still in test mode, human backup drivers sit behind the wheel ready to take over if it misfires, and rides are only bookable by staff. Moia plans to start carrying regular Hamburgers in the coming months.

Americans will likely be next. In April, Volkswagen said it would deploy thousands of self-driving minivans in the U.S. through an agreement with Uber, starting in Los Angeles in 2026.

Mint Hyderabad'den DAHA FAZLA HİKAYE

Mint Hyderabad

Mint Hyderabad

Nvidia, Eli Lilly to invest $1 bn in AI lab

Nvidia Corp. plans to invest $1 billion over five years in a new laboratory with Eli Lilly & Co., aiming to speed up the use of artificial intelligence (AI) in the pharmaceutical industry.

time to read

1 min

January 13, 2026

Mint Hyderabad

Shadowfax IPO to open next week

Logistics services provider Shadowfax is set to launch its ₹1,900-crore initial public offering (IPO) next week, targeting a valuation of ₹7,400 crore, people familiar with the matter said on Monday.

time to read

1 min

January 13, 2026

Mint Hyderabad

The US climate cop-out should galvanize others

America's withdrawal from the global battle against climate change is a signal for the rest of the world to unite for the greater good. The cause is vital, not the participation of the US

time to read

2 mins

January 13, 2026

Mint Hyderabad

Toyota pushes for fuel norm clarity

The government should soon come out with the final notification for the next phase of India’s Corporate Average Fuel Efficiency standards so that the industry can prepare accordingly, according to a senior Toyota Kirloskar Motor executive.

time to read

1 min

January 13, 2026

Mint Hyderabad

Food effect lifts Dec CPI inflation

India's retail inflation rose for the second successive month in December, data released by the statistics ministry on Monday showed, driven by a moderation in negative food inflation and an uptick in core inflation.

time to read

1 min

January 13, 2026

Mint Hyderabad

Mint Hyderabad

Commissions trump advice in wealth management biz

surge on rising affluence, strong economic growth, higher foreign direct investments, and the growth of the startup ecosystem.

time to read

2 mins

January 13, 2026

Mint Hyderabad

The Chinese company taking on the world's memory-chip giants

As AI demand drives prices up, CXMT beats Washington's curbs to vie with Micron and South Korean leaders

time to read

4 mins

January 13, 2026

Mint Hyderabad

HC lifts ban on Zydus cancer biosimilar till patent expiry

In a relief for Zydus Lifesciences, a division bench of the Delhi High Court on Monday allowed the drugmaker to sell and market its biosimilar of the anticancer drug nivolumab in India, citing public interest.

time to read

2 mins

January 13, 2026

Mint Hyderabad

Fix GST on capital goods to revive private investment

India faces a paradox today.

time to read

3 mins

January 13, 2026

Mint Hyderabad

Mint Hyderabad

Feeling tired? It could be too many messages

The cumulative stress of constant notifications is leaving many emotionally burnt out. Tackling it requires small, sustainable changes

time to read

4 mins

January 13, 2026

Listen

Translate

Share

-
+

Change font size